12:00 AM
 | 
Oct 15, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Zonegran zonisamide regulatory update

The Scottish Medicines Consortium recommended against the use of Zonegran zonisamide on the National Health Service (NHS) in Scotland as a monotherapy in newly diagnosed epilepsy patients with partial seizures, with and without second generalization...

Read the full 155 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >